H.R. 2069 · 114th Congress

Neuromyelitis Optica Consortium Act

Stage
In committee
Introduced
2015-04-28
Latest action
2015-05-01 · Referred to the Subcommittee on Health.

Summary

Neuromyelitis Optica Consortium Act

This bill amends the Public Health Service Act to require the National Institutes of Health to establish, administer, and coordinate a National Neuromyelitis Optica (NMO) Consortium to:

award grants for research on the causes of, and the risk factors and biomarkers associated with, NMO (a neurological disease leading to blindness and paralysis); assemble a panel of experts to provide ongoing guidance and recommendations on research design and protocols; and designate a central laboratory to collect, analyze, and aggregate data from this research and to make the data and analysis available to researchers.